These metabolic differences between IDH1-WT (increased glutamate, citrate; Figure 4C) and IDH1-mut glioblastoma (decreased glutamate, citrate; Figure 4C) reflect different clinical outcome of these entities. This evidence concerns the gene IDH1 and glioblastoma.